Predictions
Xortx Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.75
06.03.24
06.03.24
-
06.03.25
06.03.25
-3.37%
16.03.24
16.03.24
Probably not worthwhile Investment
Albemarle Corp
Start price
Target price
Perf. (%)
€102.40
05.03.24
05.03.24
-
05.03.25
05.03.25
16.45%
03.04.24
03.04.24
Growths faster than the competition
Ocean Biomedical Inc.
Start price
Target price
Perf. (%)
€6.65
05.03.24
05.03.24
-
05.03.25
05.03.25
-44.36%
16.03.24
16.03.24
Probably not worthwhile Investment
BYD Co. Ltd
Start price
Target price
Perf. (%)
€22.46
05.03.24
05.03.24
€23.00
05.03.25
05.03.25
8.37%
12.03.24
12.03.24
Risky Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
Netflix Inc.
Start price
Target price
Perf. (%)
€565.10
05.03.24
05.03.24
€570.00
05.03.25
05.03.25
4.58%
12.04.24
12.04.24
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Barrick Gold Corp
Start price
Target price
Perf. (%)
€14.38
05.03.24
05.03.24
€15.00
05.03.25
05.03.25
4.28%
28.03.24
28.03.24
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Ocean Biomedical Inc.
Start price
Target price
Perf. (%)
€3.92
04.03.24
04.03.24
-
04.03.25
04.03.25
-5.61%
16.03.24
16.03.24
Innovative
No uniques
Probably not worthwhile Investment
Helma Eigenheimbau AG
Start price
Target price
Perf. (%)
€0.66
04.03.24
04.03.24
-
04.03.25
04.03.25
-59.55%
16.03.24
16.03.24
Could be worthwhile Investment >10% per year
Good culture
Below average Management
Msp Recovery Inc.
Start price
Target price
Perf. (%)
€1.13
04.03.24
04.03.24
-
04.03.25
04.03.25
-33.19%
16.03.24
16.03.24
Capable Management
Could be worthwhile Investment >10% per year
Good culture
Few uniques
Super Micro Computer
Start price
Target price
Perf. (%)
€1,044.5
04.03.24
04.03.24
-
04.03.25
04.03.25
-3.73%
16.03.24
16.03.24
Capable Management
Probably not worthwhile Investment
Few uniques
Sixt SE ST
Start price
Target price
Perf. (%)
€89.80
04.03.24
04.03.24
€91.00
04.03.25
04.03.25
4.40%
18.04.24
18.04.24
EBIT growth >5% per year expected
Top Rating
Very valuable balance sheet
Normal challenges to pay loans and raise capital
Barrick Gold Corp
Start price
Target price
Perf. (%)
€13.86
04.03.24
04.03.24
€14.00
04.03.25
04.03.25
3.75%
05.03.24
05.03.24
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Minim Inc.
Start price
Target price
Perf. (%)
€4.50
04.03.24
04.03.24
€11.00
04.03.25
04.03.25
22.22%
18.03.24
18.03.24
Could be very worthwhile Investment >20% year
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€3.74
04.03.24
04.03.24
-
04.03.25
04.03.25
-24.06%
17.03.24
17.03.24
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€25.60
04.03.24
04.03.24
-
04.03.25
04.03.25
-0.78%
15.03.24
15.03.24
Risky Investment
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€4.00
04.03.24
04.03.24
-
04.03.25
04.03.25
-13.00%
16.03.24
16.03.24
Probably not worthwhile Investment
Annovis Bio Inc.
Start price
Target price
Perf. (%)
€8.50
03.03.24
03.03.24
-
03.03.25
03.03.25
0.12%
15.03.24
15.03.24
Risky Investment
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.96
03.03.24
03.03.24
-
03.03.25
03.03.25
10.06%
15.03.24
15.03.24
Could be very worthwhile Investment >20% year
Peloton Interactive Inc.
Start price
Target price
Perf. (%)
€4.23
02.03.24
02.03.24
€5.00
02.03.25
02.03.25
4.98%
11.03.24
11.03.24
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Very positive Cash Flow expected